The BTRR (BLM/TOP3A/RMI1/RMI2) complex resolves DNA replication and recombination intermediates, as well as mitotic DNA intertwinements, yet how its diverse activities are regulated remains unclear. Here, we identify key determinants of stable assembly of the BTRR complex on ultrafine DNA bridges (UFBs). We reveal that...
U. Aliyaskarova, Özgün Özer, Mahafuzul Sumon et al.· bioRxiv· 0 citations
Together, these findings identify TUT4/7 as druggable targets, whose inactivation suppresses AML while sparing normal hematopoiesis, and represents a promising therapeutic strategy in combination with venetoclax.
Christopher Mapperley, Elise Georges, A. Azar et al.· Science Advances· 0 citations
It is demonstrated that correction of BCOR mutation by CRISPR–Cas9 only partially restores the wildtype molecular state, highlighting the importance of early detection and monitoring of adaptive mutations in hiPSC cultures.
C. Badja, S. Boushaki, Yogesh Kumar et al.· bioRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.